RVTY: Diagnostics and life sciences growth, AI-driven innovation, and strong backlog fuel positive outlook
The company reported strong Q2 results, driven by diagnostics and a recovering life sciences segment, with significant backlog in high-content screening instruments and robust growth in China. Software innovation and AI integration are accelerating, while operational improvements and strategic acqu…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.